Quoin Pharmaceuticals Ltd - ADR (QNRX) is higher by 15.97% Friday In Premarket Trading

Quoin Pharmaceuticals Ltd - ADR (QNRX) is higher by Friday morning, with the stock increasing 15.97% in pre-market trading to 1.38. QNRX's short-term technical score of 10 indicates that the stock has traded less bullishly over the last month than 90% of stocks on the market. In the Biotechnology industry, which ranks 88 out of 146 industries, the stock ranks higher than 14% of stocks. Quoin Pharmaceuticals Ltd - ADR has fallen 64.05% over the past month, closing at $3.36 on February 9. During this period of time, the stock fell as low as $1.30 and as high as $6.18. QNRX has an average analyst recommendation of Buy. The company has an average price target of $10.97.

QNRX has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on QNRX!

See Full QNRX Report

Quoin Pharmaceuticals Ltd - ADR has a Long-Term Technical rank of 1. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 99% of the market scoring higher. In the Biotechnology industry which is number 49 by this metric, QNRX ranks better than 49% of stocks.

Important Dates for Investors in QNRX:

-Quoin Pharmaceuticals Ltd - ADR is set to release earnings on 2024-03-13. Over the last 12 months, the company has reported EPS of $1.38. -We do not have a set dividend date for Quoin Pharmaceuticals Ltd - ADR at this time. Click Here To Get The Full Report on Quoin Pharmaceuticals Ltd - ADR (QNRX)